|Bid||0.0000 x 0|
|Ask||0.0000 x 0|
|Day's Range||0.6541 - 0.6777|
|52 Week Range||0.4440 - 1.2600|
|Beta (3Y Monthly)||8.62|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Auxly Cannabis Group Inc. (TSX.V - XLY) ("Auxly") and Kindred Partners Inc. (“Kindred”) are pleased to announce that they have entered into a brokerage agreement pursuant to which Kindred will act as Auxly’s exclusive sales agent for its adult-use cannabis products in Canada. Kindred, a wholly-owned subsidiary of Breakthru Beverage Group, is a Toronto-based specialty cannabis brokerage serving the adult-use market. Kindred leverages the deep experience of its sister-company, Breakthru Beverage Canada, in working with Canadian Provincial control boards, licensed distributors and retailers to broker regulated cannabis products for the adult-use market.
Auxly Cannabis Group Inc. (TSX.V - XLY) ("Auxly" or the "Company") today announced that its wholly-owned subsidiaries, Dosecann Inc. (“Dosecann”) and Kolab Project Inc. (“Kolab”) have both been authorized by Health Canada to sell cannabis oil under the Cannabis Regulations. The issuance of these sales licences marks a significant milestone for Auxly in furthering its strategy to deliver branded derivative cannabis products to market when such products become legal later this year.
Auxly Cannabis Group Inc. (TSX.V - XLY) ("Auxly" or the "Company"), together with its strategic partner, Atlantic Cultivation (“Atlantic”), is thrilled to announce today that it has entered into a comprehensive supply, development and retail agreement with the Province of Newfoundland and Labrador. The agreement marks a significant milestone in the establishment of Auxly’s presence in Atlantic Canada. Under the terms of the agreement, Atlantic will be eligible to apply to operate five new retail locations in the province.
Following a long downturn in wholesale marijuana prices, Colorado, Oregon, and Washington are suddenly pulling a 180.
Auxly Cannabis Group Inc. (TSX.V - XLY) ("Auxly" or the "Company") today announced that it has entered into a hemp cultivation and purchase agreement (the “Agreement”) pursuant to which the Company has agreed to act as the financial sponsor for the development of a hemp farming co-operative consisting of six individual hemp licence holders pursuant to the Cannabis Act (collectively, the “Hemp Farmers”) located in Prince Edward Island. To date, the Company has funded $4.5 million of the approximately $6 million it will advance and the Hemp Farmers have planted nearly 300 acres of hemp, which is expected to result in approximately 100,000 kilograms of hemp biomass.
VANCOUVER, British Columbia, Aug. 16, 2019 -- Auxly Cannabis Group Inc. (TSX.V - XLY) (OTCQX: CBWTF) ("Auxly" or the "Company") today released its financial results for the.
Auxly Cannabis Group Inc. (TSX.V - XLY) ("Auxly" or the "Company") is pleased to announce that its joint venture partner, Sunens Farms Inc. (“Sunens”), has entered into a term sheet for a syndicated credit facility, with the Bank of Montreal (“BMO”) as Lead Underwriter and, subject to the satisfaction of certain customary closing conditions and the finalization of definitive loan documentation, expects to receive debt financing in the aggregate amount of approximately $84 million. The syndicated senior debt facility will be for $71.5 million (the “Credit Facility”) for a three-year term together with a BMO $12.5 million leasing facility (the “Leasing Facility”). Sunens is a fully automated, purpose-built greenhouse for cannabis cultivation currently under construction in Leamington, Ontario.
Auxly Cannabis Group Inc. (TSX.V - XLY) ("Auxly" or the "Company") today announced that its Board of Directors has named Hugo Alves, President, to succeed Chuck Rifici as CEO, effective August 27, 2019. Mr. Rifici will continue to serve as Chairman of Auxly’s Board of Directors.
A lot of shareholders and former shareholders have soured on Auxly Cannabis Group (CBWTF) because of low performance, a weak stable of companies, and questions about its ability to survive long enough to deliver on its streaming business model.The company recently received a reprieve from some of this concerns after it was announced the British-based tobacco firm Imperial Brands was investing C$123 million ($93.4 million) into Auxly.Terms of the dealThe C$123 million investment came by means of a convertible debenture. The conversion price was set at C$0.81 per share. At the time of the announcement it presented an 11 percent premium over the closing price of the prior trading session. Per terms of the deal Imperial Brands included an option to exercise the note at any time during the three-year term. If Imperial chooses not to convert, the debenture is required to be repaid in full.On the part of Imperial, that's a very safe bet. It's getting just under 20 percent of Auxly Cannabis for what is essentially kicking the tires, i.e., a trial run.Benefit to AuxlyEven though Auxly predictably got a quick boost to its share price when the cash infusion was announced, it hasn't been able to hold, and the share price has dropped back to trading between 60 cents and 70 cents. This, as mentioned earlier, is because of the negative sentiment associated from the company on past under performance and growing discontent from many retail shareholders in particular.That said, it has to be admitted that the C$123 million definitely changes the possibilities and flexibility of the company, as it should be able to complete construction on its wholly-owned farm construction, along with a joint venture it has been working on.In the near term, the additional capital will help it build out a portfolio of derivative products that will be allowed to be sold in Canada in the latter part of 2019.Of those, vapes are projected and expected to be one of the top-selling derivatives, which will strengthened by Auxly's access to Nerudia products, which competes in the vaping market. Vapes and other derivatives command higher prices, which will generate wider margins and earnings.Last, the distribution network of Imperial Brands extends to global markets, and that should provide Auxly with fast access to those markets. Imperial's experience in marketing to those disparate markets should allow Auxly to leverage it to accelerated growth.ConclusionIt can't be overstated how much Auxly Cannabis Group needed this type of deal. The company had been floundering and many questions have been raised by disgruntled shareholders and former investors as to the viability of the business model of the company, and its ability to execute it profitably.With the company's name now being associated with Imperial Brands and its C$123 million investment, it has definitely given it a chance to change that negative sentiment around and make believers of shareholders once again.In the near term the vapes business will provide the immediate impact on the performance of the company, although that won't start to happen meaningfully in the first quarter of calendar year 2020. The earnings report for that time period will give a glimpse into what expectations for investors will be.At the same time, expectations need to be tempered because it's uncertain at what pace products will be distributed and how long it'll take to fully serve the Canadian market. It could take longer than some think at this time, which is probably part of the reason the temporary boost in the share price of the company didn't hold.Auxly will definitely need to use some of that capital to land more streaming deals as well, as it needs to show some ability to generate a predictable stream of income, which is one of the attractions a streaming company of any type has for investors.For now, Auxly Cannabis remains a high risk stock in my opinion, even with the cash infusion from Imperial. It'll take time for it to turn itself around, but if it can, and the vape business takes off relatively soon after Canada allows derivatives to be sold, it could start to change the narrative to a more positive one for the company.I think, with the company as it is today, most investors are going to maintain a wait-and-see attitude until after the first earnings report of 2020, to get more visibility on the viability of the company and how long it'll take for it to generate some sustainable revenue.The good news is the capital should allow it to enter into more deals that may provide it with more revenue in the short term. If that happens, the share price could take off before 2020.See price targets and analyst ratings on TipRanks
Auxly Cannabis Group Inc. (XLY.V) (CBWTF) (“Auxly”), an international cannabis company, today announced that Imperial Brands PLC (“Imperial Brands”) will invest approximately $123 million in Auxly by way of a convertible debenture and grant Auxly global licences to Imperial Brands’ vaping technology and access to its vapor innovation business, Nerudia (the “Transaction”). “This investment from Imperial Brands will enhance Auxly’s ability to continue to deliver on our business plans and accelerate our growth initiatives to expand our portfolio of branded derivative products,” said Hugo Alves, President of Auxly.
Auxly Cannabis Group Inc. (TSX.V - XLY) ("Auxly" or the "Company") today announced the official opening of LAB001, the flagship retail location of its wholly- owned subsidiary, Kolab Project Inc. (“Kolab”). LAB001, located at #7, 3427 - 50 Avenue in Lloydminster, Saskatchewan, is open and operational as of July 11, 2019. In conjunction with the opening of the retail location, Kolab is now able to commence province-wide e-commerce sales in Saskatchewan.
The cannabis revolution is just getting started, but the real money is being made behind the scenes, right under the noses of some of the industry’s most savvy investors
Auxly Cannabis Group Inc. (TSX.V - XLY) ("Auxly" or the "Company") is pleased to announce the appointment of Andrew MacMillan as Vice President, Commercial Business Development. Mr. MacMillan most recently served as the Chief Executive Officer of the PEI Liquor Control Commission, which is responsible for the regulation and sale of cannabis through its related corporation, the Cannabis Management Corporation. In his role as CEO, Mr. MacMillan oversaw the regulation of cannabis and the establishment of the PEI Cannabis retail operations, which are regarded as among the most successful in the country.
Auxly Cannabis Group Inc. (TSX.V - XLY) ("Auxly") is pleased to announce that Auxly’s wholly owned subsidiary, Dosecann Inc. (“Dosecann”) has entered into a definitive agreement with Capsugel Inc., a subsidiary of Lonza Group Ltd. (“Capsugel”), to provide Dosecann with a complete line of equipment for capsule filling and sealing, including a state-of-the-art LEMS® machine, Lonza’s proprietary liquid-filled Capsugel® Licaps® capsules, and rights to its capsule filling and sealing LEMS® technology. In addition, Dosecann and Lonza will work collaboratively on new product formulation for cannabis capsule products. Lonza’s technology is currently used for several functional improvements in health and nutritional applications, including bioavailability enhancement, taste and odor masking, combination products, and controlled and delayed release.
NEW YORK , June 4, 2019 /PRNewswire/ -- OTC Markets Group Inc. (OTCQX: OTCM), operator of financial markets for 10,000 U.S. and global securities, today announced the launch of the OTCQX® Cannabis Index ...
Auxly recorded its first marijuana sales in Q1, but revenue isn't expected to really pick up until October.
VANCOUVER, British Columbia, May 27, 2019 -- Auxly Cannabis Group Inc. (TSX.V - XLY) (OTCQX: CBWTF) ("Auxly" or the "Company") today released its financial results for the.
Cannabis cultivation requires enormous amounts of energy, and water, and the companies that employ smart solutions are now pulling ahead in the highly competitive cannabis boom
HENDERSON, NV / ACCESSWIRE / April 9, 2019 / With some analysts calling for a potential recession, they are predicting the cannabis industry will be one of the top industries capable of delivering a healthy ...
Auxly Cannabis Group Inc. (TSX.V - XLY) ("Auxly" or the "Company") today announced that its wholly-owned subsidiary, Robinsons Cannabis Inc. (“Robinsons”), has been granted standard cultivation and processing licences by Health Canada pursuant to the Cannabis Act and Cannabis Regulations. The licences give Robinsons the ability to begin cultivation at its fully constructed 27,700 square-foot facility in Kentville, Nova Scotia, which was purpose-built to produce high-quality cannabis. Led by experienced head grower Andrew Robinson, Robinsons is uniquely positioned to capture the attention of luxury cannabis consumers, with operations built on a devotion to uncompromising quality and a premium cannabis experience.